recipients with an occluded or absent middle hepatic vein was worse than those with a patent middle hepatic vein. The hospital mortality rate was also higher in those with an occluded middle hepatic vein (3/9 vs. 5/84, P ϭ 0.028). Conclusions: Inclusion of the middle hepatic vein in right-lobe LDLT is safe and is essential for optimum graft function and patient survival. R ight-lobe liver donor liver transplantation (LDLT) is adopted as one of the solutions to overcome the graft shortage in adult patients waiting for liver transplantation. 1 However, the major controversy lies in the necessity of including the middle hepatic vein in the graft and the safety of the donor. The middle hepatic vein lies in the midplane of the liver and drains the right anterior sector and segment IV. 2 Inclusion of the middle hepatic vein in the right lobe graft ensures adequate and uniform venous drainage of the graft, but it may lead to congestion of the segment IV in the donor. When we initiated the right-lobe LDLT for adults in 1996, 3 the middle hepatic vein was included in the graft, but other centers feared that the donor risk would be substantially increased and did not include the middle hepatic vein in the graft. 4 -7 In this study, we analyzed the outcome of the donors who had donated the middle hepatic vein in the graft to determine whether the inclusion of the middle hepatic vein is safe. We also analyzed the outcome of the recipients who had the graft middle hepatic vein occluded to determine whether the middle hepatic vein is necessary for achieving a better early graft function.
PATIENTS AND METHODS
From May 1996 to January 2002, 178 donors were worked up for right-lobe LDLT. The donors underwent routine hematology, renal and liver biochemistry, and viral serology screening. Detailed information about the donor operation was given, including the possibility of a complication rate of 15% and a mortality rate of 1%. Clinical psychological assessment was routinely made. If deemed appropriate for donation, they underwent computed tomography (CT) and hepatic angiography for detailed study of the liver volume, and intrahepatic and extrahepatic vasculature. By CT volumetry, the donors were considered suitable for donation if the estimated right-lobe graft volume was more than 40% of the estimated standard liver mass of the recipient (calculated by the formula devised by Urata 8 ) and the left-lobe volume was more than 30% of the total liver volume. 9 Hepatic angiography was performed mainly to identify the location of the origin of the segment IV hepatic artery. The CT scan was studied thoroughly with respect to the anatomical arrangement of the hepatic veins and their branches.
Intraoperatively, the donor was placed in a position to avoid pressure sores. Devices to prevent hypothermia and deep vein thrombosis were provided. Prophylactic antibiotic was given at the time of induction of general anesthesia. Through a bilateral subcostal incision with midline extension, the liver was explored and examined thoroughly by Doppler ultrasonography. The location of the segment IVb hepatic vein was defined. Operative cholangiography was performed via cystic duct cannulation to determine the most appropriate site of the division of the right hepatic duct and avoid stenosis of the confluence of the hepatic ducts. The right hepatic artery and right portal vein were freed with care to preserve any segment IV hepatic artery arising from the right hepatic artery. Rotation and mobilization of the right lobe were performed. Rotation of the right lobe was intermittent to prevent prolonged twisting of the inflow and outflow vascular pedicles and ischemic injury to the left lobe. Gauze was not present over the liver hilum during right lobe mobilization because it prevented complete rotation of the right lobe and predisposed to occlusion of vascular inflow of the liver. The posterior surface of the paracaval portion of the caudate lobe was separated from the right and anterior surface of the inferior vena cava by dividing the small branches of hepatic veins. The inferior right hepatic vein (draining segment VI) or middle right hepatic vein (draining segment VII) 10 greater than 5 mm were preserved with the graft. The liver was then transected at the midplane by ultrasonic dissector without inflow or outflow vascular occlusion. The midplane of the liver 11 was determined by temporary occlusion of the right hepatic artery and right portal vein. If uncertainty existed, intraoperative ultrasonography was performed again. The longitudinal plane on which both the middle hepatic vein and inferior vena cava could be seen simultaneously was the correct plane. 12 On approaching the liver hilum, the right hepatic duct together with the surrounding hilar plate were divided at the most appropriate site as determined by cholangiography. If needed, cholangiography was repeated before and after division of the right hepatic duct. The transection of the liver was performed all the way down to the root of the middle hepatic vein with the left hepatic vein or inferior vena cava. The assistant facilitated the transection by inserting the left index finger in the space between the inferior vena cava and the caudate lobe and lifting up the liver. A major segment IVb 13 hepatic vein entering the middle hepatic vein near the root of middle hepatic vein was preserved as far as possible. The middle hepatic vein was transected proximal to this segment IVb hepatic vein. After removal of the right-lobe liver graft, intraoperative Doppler ultrasonography was repeated to ascertain integrity of the left hepatic artery, left portal vein, and left hepatic vein. The left and segment IV portal vein were also studied for the flow pattern in the last 47 donors. Methylene blue was injected into the bile duct to identify the site of bile leakage. The falciform ligament was sutured to the anterior abdominal wall to prevent rotation and outflow obstruction of the left lobe. 14 Abdominal drain was not used in the last 68 donors.
Postoperatively, the donor was nursed in the intensive care unit with attention to provide adequate organ oxygenation and perfusion and pain relief. Hypothermia was prevented by warming devices. Early parenteral nutritional support was given in 23 donors of the early part of the series but not in the later patients. Oral nutrition was encouraged once bowel activity returned. Chest physiotherapy and incentive spirometry were routinely given. Regular imaging of the remnant liver was not performed. All complications were recorded prospectively by a research assistant.
All recipients were cared in the intensive care unit. Immunosuppressive protocol consisted of steroid and FK506. Systemic investigation for the patency of the middle hepatic vein in the graft during outpatient follow-up was not performed.
In this study, all values were expressed as median and range. Mann-Whitney U test and Wilcoxon signed ranked test were used to compare continuous variables. 2 
RESULTS
Complication related to procedures of donor evaluation was not seen. Ninety-three donors eventually completed right-lobe donor hepatectomy. The remaining donors did not undergo hepatectomy because of withdrawal of intention to donate (n ϭ 34), ABO blood type incompatibility (n ϭ 23), hepatitis B or C positivity (n ϭ 17), fatty liver (n ϭ 2), psychological instability (n ϭ 1), insufficient liver remnant (n ϭ 2), hypersensitivity to antibiotic (n ϭ 1), and vascular abnormality (n ϭ 1). The donor who was declined because of vascular abnormality had a long common trunk of the middle and left hepatic veins. The middle hepatic vein was considered too short for a safe anastomosis. Three donors had aborted laparotomy because of abnormal findings in the liver biopsy (n ϭ 2) and massive bowel gangrene found in recipient laparotomy (n ϭ 1). The median right lobe volume estimated by CT volumetry was 703.5 mL (range, 450 to 1160 mL), which was 56% (36.8 to 102.7%) of the estimated standard liver volume of the recipient. No donor was rejected because of inadequate right lobe volume. The median left lobe volume of the donors was 368 mL (range, 217 to 594 mL) or 33.9% (range, 23.6% to 45.2%) of the total liver volume. Seventeen donors had left-lobe volume less than 30% of the total liver volume. They underwent donor hepatectomy because of high-urgency status of the recipients and lack of other appropriate donors.
On CT scan, the middle hepatic vein of these 93 donors was independent of the left hepatic vein draining into the inferior vena cava in 38 donors (41%). The middle hepatic vein was larger than the right hepatic vein at the root in 14 donors (15%) and of about the equal size of the right hepatic vein in 40 donors (43%). The middle hepatic vein was smaller than the left hepatic vein at the root in 23 donors (25%) and approximately equal to the size of the left hepatic vein in 63 donors (68%). The segment IVb hepatic veins, 1 to 2 in number as seen in the CT scan, drained into the middle hepatic vein (n ϭ 76, 81%), left hepatic vein (n ϭ 30, 32%), or junction of the middle and left hepatic vein (n ϭ 1). In 66 donors (71%), an umbilical vein was obvious in the CT scan. The middle hepatic vein also received one to three branches of the segment IVa hepatic vein (n ϭ 91, 98%), 1 to 3 branches of the segment VIII hepatic vein (n ϭ 92, 99%), and 1 to 4 branches of the segment V hepatic vein (n ϭ 91, 98%). In 15 donors (16%), the segment VIII was also drained by a large trunk derived from the right hepatic vein ( Fig. 1 ). On tracing the course of the middle hepatic vein, the main trunk was seen originating in segment V in 28 donors (30%), in segment VI in 2 donors, and near the gallbladder fossa in the others. Obvious inferior right hepatic vein and middle right hepatic vein were seen in 43 donors (46%) and 11 donors (12%), respectively.
Intraoperatively, all except donor 85 had donation of the middle hepatic vein in the graft. In donor 85, the segment III hepatic vein drained into the middle hepatic vein at a level much higher than the segment VIII hepatic vein (Fig. 2) . Decision was made to preserve the middle hepatic vein with the donor and only the segment VIII hepatic vein was included in the graft and anastomosed to the inferior vena cava. In 44 donors (48%), at least 1 branch of the segment IVb hepatic vein was preserved in the donor either the middle hepatic vein was divided proximal to it ( Fig. 3 ) or the segment IVb hepatic vein drained into the left hepatic vein. Excessive bleeding was not seen on dissection around the middle hepatic vein near the root with the inferior vena cava. After removal of the right lobe graft, Doppler ultrasonography showed normal flow direction in segment IV portal vein in 28 (60%) donors, static flow in 10 (21%) donors, and reversed flow direction in 9 (19%) donors.
Intraoperatively, mishap occurred in donor 2. At the time of harvesting, the vascular clamp applying to the junction of the middle and left hepatic veins occluded the left hepatic vein, resulting in left-lobe congestion. The mistake was rectified immediately. Portal vein thrombosis was noticed in donor 41 by intraoperative ultrasonography. It was because the division of the right portal vein was too close to the main portal vein, which was occluded by a purse-string effect of the suture. The suture was removed. After throm- Middle Hepatic Vein in Liver Graft in Right-lobe bectomy, the right portal vein orifice was sutured transversely. Both donors were well afterwards. The duration of the donor operation was 6.3 to 15.5 hours (median, 8.7 hours). The median blood loss of the operation was 466 mL (range, 42 to 1600 mL). Donor 13, who had thalassemia, received 1 unit of blood transfusion. Donors 3 and 5 received 1040 and 540 mL of exogenous fresh frozen plasma, respectively. The other donors did not receive blood or blood products.
The median duration of hospital stay was 10 days (range, 5 to 38 days). There was no donor hospital death. Postoperative complications occurred in 24 donors (26%) ( Table 1 ). Most of the complications were wound infection, which was mostly minor and resulted in incision hernia in one donor only. Cholestasis (serum total bilirubin Ͼ100 mol/L on postoperative day 7) was seen in 4 donors, probably owing to fatty change (donors 2 and 8) or a relatively small liver remnant (31%) together with mild portal fibrosis and fatty infiltration (5%) (donors 55 and 71). Bile duct stenosis was found in donors 3 and 68, among whom the first required relaparotomy and was reported previously. 3 Donor 68 had balloon dilation of the stenosis via endoscopic retrograde cholangiopancreatography. Both were free from symptoms afterwards. None of the donors had bile leakage from the liver transection surface or right hepatic duct stump. Donor 29 had bleeding duodenal ulcer and received 2 units of exogenous blood. Ten donors had to be readmitted because of cholestasis (n ϭ 1), bowel obstruction (n ϭ 1), bile duct stricture (n ϭ 2), repair of incision hernia (n ϭ 1), urinary tract infection (n ϭ 1) and wound infection (n ϭ 4). The incidence of septic complications did not correlate with the volume of the remnant liver. There was no statistical difference in postoperative liver function as measured by the international normalized ratio between donors with remnant volume Ͼ30% or Ͻ30%. There was no donor death after a median follow-up period of 19.8 months (range, 2 to 72 months).
Data on the postoperative hematology and liver and renal biochemistry of the donors are shown in Figures 4 -6 . Peak or trough values of platelet count, international normalized ratio, serum bilirubin, and serum urea were seen on postoperative days 2 or 3. The values tended to be normalized towards the end of the first week. The data were further analyzed with respect to whether all segment IVb hepatic veins had been sacrificed or not. The international normalized ratio was significantly higher on postoperative day 1 in the donors who had all the segment IVb hepatic veins sacrificed ( Fig. 7) . Otherwise, there was no difference in the postoperative parameters between the 2 groups. The median hospital stay was also similar (11 days vs. 9 days, P ϭ 0.09).
Implantation of the right-lobe graft was performed by anastomosing the right hepatic vein, inferior right hepatic vein and middle hepatic vein successively, except recipient 1. In this recipient, the middle hepatic vein was not anastomosed before portal vein reperfusion because we wished to reduce the warm ischemic time. However, severe graft congestion and massive bleeding from the transection surface was noted. After reconstruction of the middle hepatic vein, the graft congestion disappeared. All recipients had patent right hepatic vein anastomosis. In recipients 10, 28, 39, 60, 72, 82, and 87, the middle hepatic vein was found to be occluded on intraoperative Doppler ultrasonography. The occlusion was the result of technical errors resulting in twisting of the middle hepatic vein or folding of the middle hepatic vein induced by graft expansion on reperfusion. Reanastomosis of the middle hepatic vein restored the blood flow and resolved liver congestion except in recipients 10, 60, and 87. Recipient 85, who received a graft with the segment VIII hepatic vein only, had congestion in segment V and part 
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Middle Hepatic Vein in Liver Graft in Right-lobe of segment VIII (Fig. 8a) . The dusky area disappeared after hepatic artery blood flow was established ( Fig. 8b) , but Doppler ultrasonography showed that the flow direction in the right anterior portal vein was back and forth. The postoperative hepatic and renal function of these 9 patients with absence or occlusion of the middle hepatic vein, whether reversible or permanent, was worse than that of those with a patent middle hepatic vein, given the fact that the graft weight to body weight ratios were similar between the two groups (Tables 2 and 3 ). Recipients 10 and 28 died of primary graft nonfunction, and recipient 39 died of invasive fungal infection, whereas the other 6 recipients survived but with a prolonged period of hyperbilirubinemia. For the recipients with patent middle hepatic vein, 5 (6%) patients died of fungal infection (n ϭ 1), thrombotic thrombocytopenic purpura (n ϭ 1), acute pancreatitis (n ϭ 1), leakage from bilio-enteric anastomosis (n ϭ 1), and legionnaire's disease (n ϭ 1) ( Table 3 ). The hospital mortality rate was significantly higher in recipients with an occluded middle hepatic vein (3/9 vs. 5/84, P ϭ 0.028). By Doppler ultrasonography, the median blood flow velocity in the right portal vein increased from 18.8 cm/sec (range, 6 to 100 cm/sec) before harvesting (in the donors) to 90 cm/sec (range, 22 to 220 cm/sec) after portal vein reperfusion in the recipients (P Ͻ 0.001). The median blood flow velocity in the left portal vein in the donors also increased from 14 cm/sec (range, 5 to 35 cm/sec) before harvesting to 24.95 cm/sec (range, 6 to 170 cm/sec) after harvesting (P Ͻ 0.001). The increase in flow velocity in the right portal vein of the graft was much higher than that of the left portal vein in the donor (median 70 cm/sec vs. median 10.2 cm/sec, P Ͻ 0.001).
DISCUSSION
The present study showed that inclusion of the middle hepatic vein in a right-lobe graft is safe. The margin of safety is widened if the segment IVb hepatic vein was preserved in the donor and attention was paid to preoperative evaluation, intraoperative care of the liver remnant and postoperative care of the donor. The postoperative serum bilirubin and alanine aminotransferase levels of the donors were not dif-ferent from those of the series in which the middle hepatic vein was retained in the donor. 4, 15, 16 To provide maximum safety to the donor, a rigorous study of the hepatic veins on CT scan is essential because there is a large variation in the anatomical arrangement of the middle and left hepatic veins. The main objective is to determine the line of the middle hepatic vein transection, preferably proximal to the segment IVb hepatic vein, and to avoid sacrifice of a large hepatic vein that drains a major portion of segment III and IV (Fig. 3 ). An umbilical vein, 2,17 present in about 70% of the donors, helps to drain segment IV and increase donor safety.
Despite the safety demonstrated in this series, the right-lobe donor hepatectomy should still be regarded as a major operation associated with potentially fatal complications. 18, 19 In our experience, 2 life-threatening complications (left hepatic vein occlusion and portal vein thrombosis) occurred intraoperatively. To recognize and rectify the vascular complications promptly, the surgeon must acquire the skills of Doppler ultrasonography. In our early experience, wound infection was common in the early part of the series and was probably caused by the long duration of an operation. 20 With experience, the operation duration was shortened. Together with the attention to moistening of wounds throughout the operation and administration of an additional dose of antibiotic at the time of wound closure, the incidence of wound infection could be reduced.
In this series, we continued to rely on hepatic angiography for a detailed anatomical study of the hepatic artery because the segment IV hepatic artery, which must be pro-tected to increase the donor safety, could be accurately delineated by the hepatic angiography, but not necessarily and confidently by CT reconstruction in every donor. 21 With experience and confidence, hepatic angiography could be avoided in the future. Magnetic resonance (MR) imaging and MR angiography may replace CT and hepatic angiography. 22 However, it is not known whether the MR angiography can accurately delineate the exact origin of the segment IV hepatic artery in every donor. 23 Preservation of the segment IV hepatic artery is essential for the viability of segment IV in the donor. Because the venous drainage of segment IV might be compromised, portal blood flow into segment IV might stop. The presence of hepatic arterial blood flow prevents infarction and the segment IV portal vein may become the drainage vein. The same phenomenon is observed in the right anterior sector in the right-lobe graft without the middle hepatic vein. However, there are 2 major differences. First, the graft sustains cold and warm ischemic injury, whereas segment IV in the donor does not. Second, because of preexisting portal hypertension, the flow velocity in the right portal vein after reperfusion is much higher than that in the left portal vein in the donor. Excessive portal vein blood flow may prevent blood in the right anterior sector returning to the right posterior sector. Thus, the potential harmful effect of hepatic venous occlusion is less in the donor segment IV than that of the right anterior sector in the graft.
In the absence of the middle hepatic vein, the right anterior sector suffered from congestion and damage. Meanwhile, all portal blood flows into the right posterior sector that sustains diffuse mechanical injury as the graft now become effectively small for size. 24 Restoration of the hepatic artery blood flow clears the dusky area in the right anterior sector, but this should not be interpreted as disappearance of congestion and proper functioning of the right anterior sector, because the right anterior portal vein now serves to drain the arterial blood. A large branch of the right hepatic vein may drain segment VIII, but it occurs only in about 15% and should not be relied on for adequate drainage. Without the middle hepatic vein, segment V drainage is always deficient. The size of segment V is variable. In about 30% of the donors, the main trunk of the middle hepatic vein originates in segment V indicating that segment V is the major portion of the right lobe. Occasionally, the middle hepatic vein can be traced to segment VI. 25 Finally, contrary to the common brief, the middle hepatic vein is larger than or of the same size as the right hepatic vein in about 58%. In the absence of the middle hepatic vein, venous drainage of the right lobe graft is therefore precarious.
The middle hepatic vein was not included in the rightlobe graft in several series because of the surgeons' conviction that one single large right hepatic vein anastomosis is sufficient 26 and intrahepatic collaterals are present in between more likely to be present. 26 However, such innovative procedure could not meet the requirement of segment VIII venous drainage. Moreover, the collaterals are small and do not open up fully by postoperative day 9. 28 Before the collateral appears to function, the graft function may be suboptimal and the graft may have sustained injury already. It is still controversial whether such collaterals exist in all normal persons. At present, there is no accurate imaging study to document the presence of intrahepatic collaterals preoperatively. Thus, it appears appropriate to include the middle hepatic vein in all right lobe grafts. Congestion of the right-lobe graft in the absence of the middle hepatic vein after implantation is widely recognized, 26,29 -32 although many surgeons claim that it is not an important problem. Several surgeons attempted to restore drainage of the right anterior sector by venous jump graft anastomosing prominent segment V and VIII hepatic veins into the inferior vena cava 33, 34 or anastomosing the right branch of the middle hepatic vein into the inferior vena cava directly. 30 However, there could be many branches of segment V or VIII hepatic veins. Anastomosing the most prominent branch could not guarantee uniform drainage of the right anterior sector.
In the absence of a patent middle hepatic vein, as shown in the present series, the early graft function is inferior, even though the period of occlusion was about 1 to 2 hours only. We postulated that, during that period, the right posterior sector sustained serious small-for-size graft injury. 24 To reduce the extent of small-for-size graft injury, a greater graft volume is needed, but that would reduce the number of donors suitable for donation. Therefore, the attempt to avoid small-for-size graft injury is an argument for the necessity of including the middle hepatic vein in the graft. However, it is more difficult to construct a perfect middle hepatic vein anastomosis than a right hepatic vein anastomosis because of the difficulty in judging the orientation of the donor and recipient middle hepatic veins and estimation of the required length. To achieve uniformly successful middle hepatic vein anastomosis, we have made modification of the technique in the recent patients and the detail will be elaborated in a separate report.
With the inclusion of the middle hepatic vein, the early graft function is satisfactory even among patients with acute or acute on chronic liver failure ( Table 3) . 35 This is contrary to the results of the series that did not include the middle hepatic vein in the graft. 7, 36 We believe that the good early graft function is vital for rapid recovery of patients with high metabolic demand and avoidance of over-immunosuppression. 37 In our initial report, the right lobe graft was called the extended right lobe graft because the liver transection line was about 1 cm to the left of the middle hepatic vein, so that sufficient liver was retained to protect the middle hepatic vein. 3 We subsequently found that such inclusion was not necessary and actually predisposed to infection. 12 The current technique consists of transecting the liver at the midplane of the liver. Although the transection line was deviated to the left side of the gallbladder fossa at the inferior surface of the liver to protect the right hepatic duct, 38 the amount of segment IV included in the graft is insignificant. Thus, the graft obtained with our current technique should be better named the right lobe graft with middle hepatic vein.
In conclusion, donation of the middle hepatic vein is safe provided that meticulous attention is paid to the surgical technique, imaging study, and perioperative care. Inclusion of the middle hepatic vein in the graft would avoid exclusion of donors with the middle hepatic vein larger than the right hepatic vein and is essential for uniform venous drainage of the right anterior sector and optimum graft function. Further effort will be made to reduce the postoperative complication rate of the donor.
